RutacridoneCAS# 17948-33-3 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 17948-33-3 | SDF | Download SDF |
| PubChem ID | 5281849 | Appearance | Powder |
| Formula | C19H17NO3 | M.Wt | 307.34 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-hydroxy-11-methyl-2-prop-1-en-2-yl-1,2-dihydrofuro[2,3-c]acridin-6-one | ||
| SMILES | CC(=C)C1CC2=C3C(=C(C=C2O1)O)C(=O)C4=CC=CC=C4N3C | ||
| Standard InChIKey | FHAGACMCMQYSNX-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C19H17NO3/c1-10(2)15-8-12-16(23-15)9-14(21)17-18(12)20(3)13-7-5-4-6-11(13)19(17)22/h4-7,9,15,21H,1,8H2,2-3H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Rutacridone has mutagenicity. |
| Targets | P450 (e.g. CYP17) |
Rutacridone Dilution Calculator
Rutacridone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2537 mL | 16.2686 mL | 32.5373 mL | 65.0745 mL | 81.3431 mL |
| 5 mM | 0.6507 mL | 3.2537 mL | 6.5075 mL | 13.0149 mL | 16.2686 mL |
| 10 mM | 0.3254 mL | 1.6269 mL | 3.2537 mL | 6.5075 mL | 8.1343 mL |
| 50 mM | 0.0651 mL | 0.3254 mL | 0.6507 mL | 1.3015 mL | 1.6269 mL |
| 100 mM | 0.0325 mL | 0.1627 mL | 0.3254 mL | 0.6507 mL | 0.8134 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Prucalopride Succinat
Catalog No.:BCC4708
CAS No.:179474-85-2
- Prucalopride
Catalog No.:BCC5055
CAS No.:179474-81-8
- Terrestrosin D
Catalog No.:BCN2934
CAS No.:179464-23-4
- Caspofungin Acetate
Catalog No.:BCC4895
CAS No.:179463-17-3
- PD 151746
Catalog No.:BCC5485
CAS No.:179461-52-0
- Leucodin
Catalog No.:BCN7105
CAS No.:17946-87-1
- 2-Methoxyanofinic acid
Catalog No.:BCN7632
CAS No.:179457-70-6
- SDZ 220-581 Ammonium salt
Catalog No.:BCC1940
CAS No.:179411-94-0
- SDZ 220-581 hydrochloride
Catalog No.:BCC4157
CAS No.:179411-93-9
- AH 11110 hydrochloride
Catalog No.:BCC6883
CAS No.:179388-65-9
- Macrocarpal I
Catalog No.:BCN1138
CAS No.:179388-54-6
- Macrocarpal H
Catalog No.:BCN1137
CAS No.:179388-53-5
- Venoterpine
Catalog No.:BCN3422
CAS No.:17948-42-4
- 1,2,3,4-Tetrahydronorharman-1-one
Catalog No.:BCN3690
CAS No.:17952-82-8
- PD 150606
Catalog No.:BCC2353
CAS No.:179528-45-1
- Cynaustraline
Catalog No.:BCN2048
CAS No.:17958-37-1
- Cynaustine
Catalog No.:BCN1951
CAS No.:17958-39-3
- Amabiline
Catalog No.:BCN1950
CAS No.:17958-43-9
- Macrocarpal J
Catalog No.:BCN1139
CAS No.:179603-47-5
- N-Benzoyl-leucine
Catalog No.:BCC9092
CAS No.:17966-67-5
- Aflastatin A
Catalog No.:BCN1822
CAS No.:179729-59-0
- 27-Hydroxymangiferolic acid
Catalog No.:BCN4689
CAS No.:17983-82-3
- 3-oxo-Olean-12-en-28-oic acid
Catalog No.:BCN3171
CAS No.:17990-42-0
- 7-Chlorokynurenic acid
Catalog No.:BCC6577
CAS No.:18000-24-3
Specific accumulation and revised structures of acridone alkaloid glucosides in the tips of transformed roots of Ruta graveolens.[Pubmed:15110689]
Phytochemistry. 2004 Apr;65(8):1095-100.
The root tips of Ruta graveolens (common rue) show strong autofluorescence of acridone alkaloids, which are characteristic secondary metabolites of this plant. To study the specific distribution and accumulation of acridone alkaloids in various root segments of Ruta graveolens, root material was harvested from genetically transformed root cultures and extracts were investigated by chromatographic techniques and HPLC-(1)H NMR spectroscopy. The cells of the elongation and differentiation zones contained acridone glucosides and large amounts of acridone alkaloids, mainly Rutacridone. Gravacridondiol glucoside was identified as the dominant secondary compound of the root tips and its structure revised by means of spectroscopic methods. In addition, minor acridones, including the structurally revised gravacridontriol glucoside and unknown natural products, were found in the root tip.
Inhibitory effects of furocoumarins in Salmonella typhimurium TA98 on the mutagenicity of dictamnine and rutacridone, promutagens from Ruta graveolens L.[Pubmed:1800898]
Mutagenesis. 1991 Nov;6(6):501-6.
Eight furocoumarins differing in their basic structure and substitution pattern (angular, linear, dihydrofuran type) were tested for their ability to reduce the mutagenic potency of dictamnine and Rutacridone, two alkaloids present in extracts from Ruta graveolens L. Both compounds need metabolic activation by S9 mix in order to exhibit mutagenicity in Salmonella typhimurium strain TA98. The furocoumarins used in this study did not show any mutagenicity either with or without S9 mix within the dose range tested. However, all the furocoumarins were able to inhibit the mutagenicity induced by dictamnine as well as by Rutacridone in a dose-dependent manner. Imperatorin turned out to be the most efficient inhibitor. The inhibitory effect is probably due to the inactivation of the cytochrome P450 enzyme complex which prevents the activation of the promutagens. This is indicative of the desmutagenic character of the furocoumarins. However, there is also some evidence that the reduction of the mutagenicity induced by dictamnine might be caused to a small extent by a mechanism which possibly depends on the competition with furocoumarins for the same sites in the DNA molecule.
